Kusumgar Q2 profit jumps to Rs 40.6 crore; announces Certoplast joint venture

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Kusumgar Q2 profit jumps to Rs 40.6 crore; announces Certoplast joint venture

Kusumgar Ltd reported a significant surge in Q2 FY27 profit to Rs 40.60 crore, up from Rs 10.92 crore year-on-year. Alongside the strong financial performance, the company announced a strategic joint venture with Germany's Certoplast Holding GmbH to manufacture tapes in India, with Kusumgar holding a 50.1% controlling stake.

Kusumgar Q2 Profit Climbs to Rs 40.60 Crore

Revenue grew to Rs 250.94 crore from Rs 138.78 crore in the year-ago period.

Reader Takeaway: Revenue growth and international partnership signal expansion, though definitive agreements for the JV remain pending.

What just happened

Kusumgar Ltd posted strong consolidated financial results for the quarter ended September 30, 2026. Simultaneously, the company signed a non-binding term sheet to form a joint venture with Germany-based Certoplast Holding GmbH. The proposed entity will focus on establishing a manufacturing facility for tapes in India. Kusumgar will hold a 50.1% majority stake, with Certoplast holding the remaining 49.9%.

Why this matters

The jump in Profit After Tax (PAT) to Rs 40.60 crore from Rs 10.92 crore in the corresponding quarter last year reflects improved operational scaling. The strategic tie-up with Certoplast represents a material step toward diversifying the product portfolio into specialized tape manufacturing, reducing reliance on existing lines and expanding market reach.

What changes now

The company has transition from a standalone operation to a collaborative model with an international partner. Financial metrics show improved efficiency, with Diluted EPS rising to 3.87 from 1.05 in the same quarter last year. The focus now shifts to the legal completion of the JV.

Risks to watch

Investors should note that the term sheet with Certoplast is non-binding. The venture's success depends on the execution of definitive agreements and the subsequent acquisition of statutory approvals. Delays in site commissioning or regulatory hurdles could impact the projected growth timeline.

What to track next

Watch for official filings regarding the signing of definitive agreements, the total capital expenditure allocated for the new manufacturing facility, and the projected timeline for the plant's operational start date.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.